Spotlight Correspondence
Leukemia (2003) 17, 463–465. doi:10.1038/sj.leu.2402814
Imatinib mesylate-induced molecular remission of Philadelphia chromosome-positive myelodysplastic syndrome
M W Drummond1, C J Lush2, M A Vickers3, F M Reid1, J Kaeda4 and T L Holyoake1
- 1Haemato-Oncology Section, Division of Cancer Science and Molecular Pathology, University of Glasgow, UK
- 2Department of Haematology, Raigmore Hospital, Inverness, UK
- 3Department of Haematology, Aberdeen University, Aberdeen, UK
- 4LRF Adult Leukemia Centre, MRD Group, Department of Haematology, Hammersmith Hospital, UK
Correspondence: M W Drummond, Haemato-Oncology Section, Division of Cancer Science and Molecular Pathology, Department of Medicine, University of Glasgow, 10 Alexandra Parade, Glasgow G31 2ER, UK; Fax: (44) 141-211-0414
Received 11 September 2002; Accepted 15 October 2002.
